BURL vs IP

BURL's Piotroski F-Score of 6/9 indicates stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades significantly above its Graham Number of $69.35 at $297.96, reflecting high growth expectations, while its ROE of 41.92% and strong earnings growth signal operational efficiency. However, a high P/E of 34.25, elevated Debt/Equity of 3.90, and bearish insider activity temper optimism. Analysts recommend 'buy' with a target of $339.29, suggesting upside potential despite valuation concerns.

The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 2/9, indicating weak financial health and deteriorating fundamentals. While revenue growth appears strong at 53.10%, this has not translated to the bottom line, as evidenced by a negative profit margin of -14.88% and a staggering -300% YoY EPS growth. The dividend is currently unsustainable with a payout ratio of 158.12%, signaling a high risk of a dividend cut. Technicals are completely bearish (0/100), and the stock is trading near its 52-week low despite optimistic analyst targets.